Sirdás sisdollui
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aiddostahtton
  • Principal factor analysis of p...
  • Čujuhandieđut
  • Deakstadieđáhus
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
  • Bissovaš liŋka
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Bibliográfalaš dieđut
Váldodahkkit: Generali, D, Fox, S, Buffa, F, Berruti, A, Brizzi, M, Allevi, G, Bonardi, S, Dogliotti, L, Bottini, A, Harris, A
Materiálatiipa: Conference item
Almmustuhtton: 2006
  • Oažžasuvvandieđut
  • Govvádus
  • Geahča maid
  • Bargiidšearbma

Geahča maid

  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    Dahkki: Generali, D, et al.
    Almmustuhtton: (2006)
  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    Dahkki: Generali, D, et al.
    Almmustuhtton: (2006)
  • Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
    Dahkki: Generali, D, et al.
    Almmustuhtton: (2009)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
    Dahkki: Mele, T, et al.
    Almmustuhtton: (2010)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
    Dahkki: Mele, T, et al.
    Almmustuhtton: (2010)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t